Natural Killer T-Cells

"Natural Killer T-Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A specialized subset of T-LYMPHOCYTES that exhibit features of INNATE IMMUNITY similar to that of NATURAL KILLER CELLS. They are reactive to glycolipids presented in the context of the major histocompatibility complex (MHC) class I-like molecule, CD1D ANTIGEN.

Descriptor ID	D055611
MeSH Number(s)	A11.118.637.555.567.569.290 A15.145.229.637.555.567.569.360 A15.382.490.555.567.569.470
Concept/Terms	Natural Killer T-Cells Natural Killer T-Cells Killer T-Cell, Natural Killer T-Cells, Natural Natural Killer T Cells T-Cell, Natural Killer T-Cells, Natural Killer NKT Cells Natural Killer T-Cell Natural Killer T Cell NKT Cell Invariant Natural Killer T-Cells Invariant Natural Killer T-Cells Invariant Natural Killer T Cells iNKT Cells Cell, iNKT Cells, iNKT iNKT Cell

Below are MeSH descriptors whose meaning is more general than "Natural Killer T-Cells".

Anatomy [A]
Cells [A11]
Blood Cells [A11.118]
Leukocytes [A11.118.637]
Leukocytes, Mononuclear [A11.118.637.555]
Lymphocytes [A11.118.637.555.567]
T-Lymphocytes [A11.118.637.555.567.569]
Natural Killer T-Cells [A11.118.637.555.567.569.290]
Hemic and Immune Systems [A15]
Blood [A15.145]
Blood Cells [A15.145.229]
Leukocytes [A15.145.229.637]
Leukocytes, Mononuclear [A15.145.229.637.555]
Lymphocytes [A15.145.229.637.555.567]
T-Lymphocytes [A15.145.229.637.555.567.569]
Natural Killer T-Cells [A15.145.229.637.555.567.569.360]
Immune System [A15.382]
Leukocytes [A15.382.490]
Leukocytes, Mononuclear [A15.382.490.555]
Lymphocytes [A15.382.490.555.567]
T-Lymphocytes [A15.382.490.555.567.569]
Natural Killer T-Cells [A15.382.490.555.567.569.470]

Below are MeSH descriptors whose meaning is related to "Natural Killer T-Cells".

Below are MeSH descriptors whose meaning is more specific than "Natural Killer T-Cells".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Natural Killer T-Cells" by people in this website by year, and whether "Natural Killer T-Cells" was a major or minor topic of these publications.

Bar chart showing 10 publications over 6 distinct years, with a maximum of 4 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2009	1	1	2
2011	3	1	4
2012	1	0	1
2014	0	1	1
2018	1	0	1
2020	1	0	1

Below are the most recent publications written about "Natural Killer T-Cells" by people in Profiles.

Haverkos BM, Porcu P. Improved outcomes for extranodal natural killer T-cell lymphoma. Lancet Haematol. 2020 04; 7(4):e272-e273.

View in: PubMed
Zhang B, Jiao A, Dai M, Wiest DL, Zhuang Y. Id3 Restricts ?d NKT Cell Expansion by Controlling Egr2 and c-Myc Activity. J Immunol. 2018 09 01; 201(5):1452-1459.

View in: PubMed
Gorcey L, Lewin JM, Trufant J, Meehan SA, McLellan BN. Papular eruption associated with palifermin. J Am Acad Dermatol. 2014 Sep; 71(3):e101-2.

View in: PubMed
Balato A, Zhao Y, Harberts E, Groleau P, Liu J, Fishelevich R, Gaspari AA. CD1d-dependent, iNKT-cell cytotoxicity against keratinocytes in allergic contact dermatitis. Exp Dermatol. 2012 Dec; 21(12):915-20.

View in: PubMed
Peiser M, Tralau T, Heidler J, Api AM, Arts JH, Basketter DA, English J, Diepgen TL, Fuhlbrigge RC, Gaspari AA, Johansen JD, Karlberg AT, Kimber I, Lepoittevin JP, Liebsch M, Maibach HI, Martin SF, Merk HF, Platzek T, Rustemeyer T, Schnuch A, Vandebriel RJ, White IR, Luch A. Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci. 2012 Mar; 69(5):763-81.

View in: PubMed
Hu T, Gimferrer I, Simmons A, Wiest D, Alberola-Ila J. The Ras/MAPK pathway is required for generation of iNKT cells. PLoS One. 2011 May 10; 6(5):e19890.

View in: PubMed
Yu J, Mitsui T, Wei M, Mao H, Butchar JP, Shah MV, Zhang J, Mishra A, Alvarez-Breckenridge C, Liu X, Liu S, Yokohama A, Trotta R, Marcucci G, Benson DM, Loughran TP, Tridandapani S, Caligiuri MA. NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human. J Clin Invest. 2011 Apr; 121(4):1456-70.

View in: PubMed
Miah SM, Purdy AK, Rodin NB, MacFarlane AW, Oshinsky J, Alvarez-Arias DA, Campbell KS. Ubiquitylation of an internalized killer cell Ig-like receptor by Triad3A disrupts sustained NF-?B signaling. J Immunol. 2011 Mar 01; 186(5):2959-69.

View in: PubMed
Sikder H, Zhao Y, Balato A, Chapoval A, Fishelevich R, Gade P, Singh IS, Kalvakolanu DV, Johnson PF, Gaspari AA. A central role for transcription factor C/EBP-beta in regulating CD1d gene expression in human keratinocytes. J Immunol. 2009 Aug 01; 183(3):1657-66.

View in: PubMed
Song L, Asgharzadeh S, Salo J, Engell K, Wu HW, Sposto R, Ara T, Silverman AM, DeClerck YA, Seeger RC, Metelitsa LS. Valpha24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages. J Clin Invest. 2009 Jun; 119(6):1524-36.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement